This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Deploy DuPont Strategy to Pick 4 Healthy Stocks
by Sanghamitra Saha
Why you should depend on the DuPont technique to pick solid profit-generating stocks.
Calavo Growers Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Calavo Growers has been struggling lately, but the selling pressure may be coming to an end soon.
Calavo Growers Enters Oversold Territory
by Zacks Equity Research
Calavo Growers, Inc. (CVGW) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Zacks.com featured highlights include: Calavo Growers, BMC Stock, Humana, Vipshop and AllianceBernstein
by Zacks Equity Research
Zacks.com featured highlights include: Calavo Growers, BMC Stock, Humana, Vipshop and AllianceBernstein
5 Top-Ranked DuPont-Confirmed Quality Stocks
by Sanghamitra Saha
DuPont technique examines operating management, management of assets and capital structure to find out the financial condition of a company.
Archer Daniels (ADM) Gains From Project Readiness, Costs High
by Zacks Equity Research
Archer Daniels' (ADM) focus on boosting growth across its business through Project Readiness initiative and strategic pillars look encouraging.
Calavo (CVGW) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Calavo (CVGW) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Sell Stocks for October 10th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Agriculture Operations Outlook: Tariffs to Mar Organic Gains
by Rajani Lohia
The Zacks Agriculture - Operations industry should witness gains from wooing customers with organic solutions for crop production. Yet, tariff-related headwinds remain threats to top line.
Gannett (GCI) Catches Eye: Stock Jumps 7.8%
by Zacks Equity Research
Gannett (GCI) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
3 Reasons Why Calavo (CVGW) Is a Great Growth Stock
by Zacks Equity Research
Calavo (CVGW) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here is Why Growth Investors Should Buy Calavo (CVGW) Now
by Zacks Equity Research
Calavo (CVGW) possesses solid growth attributes, which could help it handily outperform the market.
Is Calavo (CVGW) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Calavo (CVGW) possesses solid growth attributes, which could help it handily outperform the market.
Here is Why Growth Investors Should Buy Calavo (CVGW) Now
by Zacks Equity Research
Calavo (CVGW) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Play 5 Stocks With Rising P/E for a Change
by Sanghamitra Saha
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.
US-China Trade Talks to Influence Agriculture Operations Outlook
by Rajani Lohia
The U.S. agriculture exports are widely impacted by the tariff war with China, the largest importer of U.S. soybeans. Nevertheless, initial U.S.-China trade talks bring hopes for the industry.
3 Reasons Growth Investors Will Love Calavo (CVGW)
by Zacks Equity Research
Calavo (CVGW) could produce exceptional returns because of its solid growth attributes.
Zacks.com featured highlights include: Marine Products, Landstar, Nutrisystem, Calavo and Comfort Systems
by Zacks Equity Research
Zacks.com featured highlights include: Marine Products, Landstar, Nutrisystem, Calavo and Comfort Systems
Dig Into DuPont Analysis With These 5 Top-Ranked Stocks
by Zacks Equity Research
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
Brown-Forman Hits 52-Week High: What's Behind the Rally?
by Zacks Equity Research
Brown-Forman (BF.B) touches a 52-week high on the back of its robust strategies, including growth and expansion plans, solid brand portfolio along with an impressive surprise trend.
Dean Foods (DF) Stock Gains on Q1 Earnings & Sales Beat
by Zacks Equity Research
Dean Foods (DF) began 2018 on a solid note as first-quarter results outpaced the estimates. Further, its enterprise-wide productivity program to boost operational excellence is impressive.
Clorox (CLX) Q3 Earnings Beats Estimates, Trims '18 EPS View
by Zacks Equity Research
Clorox (CLX) delivered solid third-quarter fiscal 2018 results driven by its 2020 Strategy and other initiatives. However, management cut down its earnings guidance for the fiscal year.
Archer Daniels (ADM) Beats on Q1 Earnings & Sales, Up Y/Y
by Zacks Equity Research
Archer Daniels' (ADM) impressive first-quarter 2018 results can be attributed to its robust strategic initiatives. With this, the company breaks its more than three-year long trend of sales misses.
Ride on DuPont Analysis & Pick 5 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
Zacks.com highlights: Medifast, LCI Industries, Patrick Industries, Vectrus and Calavo Growers
by Zacks Equity Research
Zacks.com highlights: Medifast, LCI Industries, Patrick Industries, Vectrus and Calavo Growers